← Back to Search

Not Applicable

Apollo System for ADHD

Led By Matthew B Pontifex, PhD.
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be 8 years of age or older and under the age of 18
Participants must have diagnosed or suspected Attention Deficit Hyperactivity Disorder (ADHD)
Screening 3 weeks
Treatment Varies
Follow Up prior to and following the 8 week study protocol period.
Awards & highlights

Study Summary

This trial will test how well the Apollo System works in reducing symptoms related to ADHD.

Who is the study for?
This trial is for children aged 8-18 with ADHD who have had minimal relief from current treatments, tried multiple treatments without meeting goals, still experience symptoms on medication, or suffer from medication side effects. It's open to all genders and ethnicities.Check my eligibility
What is being tested?
The Apollo System is being tested over an 8-week period at home to see if it can reduce ADHD symptoms in children who meet the study criteria.See study design
What are the potential side effects?
The information provided does not specify side effects of the Apollo System. Typically, clinical trials monitor participants for any adverse reactions during the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 8 and 17 years old.
I have been diagnosed with or suspected to have ADHD.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to and following the 8 week study protocol period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to and following the 8 week study protocol period. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ADHD symptomatology as assessed using the ADHD-5 Rating Scale
Effect Size for Change in Behavioral Index of Interference Control
Effect Size for Change in Behavioral Index of Response Inhibition

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Commercial Apollo System DeviceExperimental Treatment1 Intervention
The active experimental group received the commercial Apollo System device.
Group II: Sham Apollo System DevicePlacebo Group1 Intervention
The control experimental group received a sham/placebo device that is identical to the commercial Apollo System device but uses an ultra-low (i.e., effectively zero) frequency pattern of vibrations.

Find a Location

Who is running the clinical trial?

The Board of MedicineUNKNOWN
3 Previous Clinical Trials
700 Total Patients Enrolled
Michigan State UniversityLead Sponsor
184 Previous Clinical Trials
601,307 Total Patients Enrolled
Matthew B Pontifex, PhD.Principal InvestigatorMichigan State University

Media Library

Apollo System (Not Applicable) Clinical Trial Eligibility Overview. Trial Name: NCT05308706 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Commercial Apollo System Device, Sham Apollo System Device
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Apollo System Highlights & Side Effects. Trial Name: NCT05308706 — N/A
Apollo System (Not Applicable) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05308706 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT05308706 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees currently being accepted for this medical trial?

"Affirmative. According to the information uploaded on clinicaltrials.gov, this medical experiment, which was initially advertised on March 18th 2022, is presently enrolling patients. The research team needs to recruit 100 people from a single location."

Answered by AI

Is there an opportunity to participate in this medical experiment?

"This medical study is seeking one-hundred candidates between the ages of 8 and 17 that have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). In order to qualify, participants must meet the following criteria: they should be aged at least eight years old and younger than eighteen; have experienced minimal symptom improvement or relief while on a single treatment plan for over twelve months; tried two or more different therapeutic methods without reaching their desired outcome; still in possession of symptoms despite taking medication; endure unwanted side effects due to pharmacological therapy. Moreover, enrollees are required to possess normal vision or corrected visual acuity necessary for completing cognitive tasks"

Answered by AI

Does this research have an age-restriction, and if so, what is it?

"This clinical trial only allows participants between the ages of 8 and 17, in line with its pre-set inclusion standards."

Answered by AI

To what extent has recruitment for this clinical trial been successful?

"Confirmed. Clinicaltrials.gov has evidence that this medical experiment is actively enrolling patients, which began posting on March 18th 2022 and was most recently updated on the 24th of March. There are 100 participants required in total from a single site."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
< 18
18 - 65
What site did they apply to?
Department of Kinesiology
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?

What questions have other patients asked about this trial?

What side effects are there? Does having a diagnosis of ASD effect results?
PatientReceived 1 prior treatment

Why did patients apply to this trial?

We have tried 3 different medications (adderall, vyvanse and Ritalin) and aren’t seeing the results we have hoped for.
PatientReceived 2+ prior treatments
I am currently on adderall and want to get off of it but because I have ADHD it's been extremely hard. Ive also been diagnosed with anxiety and depression.
PatientReceived no prior treatments
~14 spots leftby Aug 2024